AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 173 filers reported holding AXSOME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $786,542 | -9.5% | 11,254 | -0.1% | 0.71% | +100.0% |
Q4 2022 | $868,792 | +48.8% | 11,264 | -26.1% | 0.35% | +72.2% |
Q2 2022 | $584,000 | -85.9% | 15,246 | -84.8% | 0.20% | -81.2% |
Q1 2022 | $4,151,000 | +97.5% | 100,299 | +80.3% | 1.09% | +115.6% |
Q4 2021 | $2,102,000 | +22.5% | 55,629 | +6.9% | 0.51% | +29.7% |
Q3 2021 | $1,716,000 | +135.7% | 52,048 | +320.9% | 0.39% | +18.5% |
Q1 2020 | $728,000 | -36.9% | 12,367 | +10.9% | 0.33% | -9.1% |
Q4 2019 | $1,153,000 | +55.0% | 11,151 | -78.7% | 0.36% | +23.5% |
Q1 2019 | $744,000 | +26.1% | 52,268 | -75.0% | 0.29% | -5.8% |
Q4 2018 | $590,000 | +79.9% | 209,195 | +119.8% | 0.31% | +113.7% |
Q3 2018 | $328,000 | – | 95,185 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |